Alternatives to Dulaglutide
Alternatives to dulaglutide include semaglutide and tirzepatide with better weight loss. When to switch from Trulicity and what to expect.
Semaglutide A1C
Superior reduction
Tirzepatide A1C
Best in class
Trulicity niche
Tolerance + ease of use
Switch protocol
New titration required
Upgrading for Better Weight Loss
If you're on Trulicity for diabetes and want more weight loss, semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) both offer superior weight loss while maintaining excellent blood sugar control. Switching from Trulicity to these newer agents is common as insurance coverage expands.
Semaglutide offers proven cardiovascular benefit and an oral formulation. Tirzepatide offers the greatest weight loss and A1C reduction through its dual GLP-1/GIP mechanism.
When Trulicity Is the Right Choice
Reasons to stay on Trulicity include: excellent tolerance with minimal side effects, the easy hidden-needle pen design, strong insurance coverage with low copays, adequate blood sugar control at current doses, and no significant weight loss goals beyond what Trulicity provides.
For diabetes management where weight loss is not the priority, Trulicity remains a solid, well-tolerated option with the best user experience among GLP-1 injection devices.
Frequently Asked Questions
Should I switch from Trulicity to Mounjaro?
If you want better blood sugar control and/or more weight loss, tirzepatide (Mounjaro) offers superior results. Discuss with your provider, especially regarding insurance coverage and titration planning.
Is Ozempic better than Trulicity?
Semaglutide (Ozempic) provides greater A1C reduction and weight loss than dulaglutide (Trulicity) in head-to-head studies. However, Trulicity may be better tolerated and has an easier pen design.
Compare all GLP-1 medication options for diabetes
Compare pricing, reviews, and availability across 18,000+ GLP-1 providers nationwide.
Search Providers →Explore all Dulaglutide topics
Cost guides, side effect management, dosing information, insurance coverage, and more — all backed by clinical data.